Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

Review the latest multidisciplinary strategies for optimizing care of patients with CLL including discussion of effective patient education on treatment selection and toxicity management. Learn from the experts with focused commentaries brief MedicalMinute slide/audio presentations case review modules and an Interactive Decision Support Tool that provides personalized management recommendations for treatment selection.

Share

Program Content

Activities

Engaging Patients
Partnering With Patients With CLL to Make Treatment Decisions in an Evolving Therapeutic Landscape
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 17, 2021

Expires: November 16, 2022

View Activity
Emerging CLL Treatment
Emerging Treatment Options for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 21, 2022

Expires: April 20, 2023

View Activity
CLL Case
Cases in CLL: Frontline Therapy Selection and Clinical Trial Considerations for a Patient With Multiple Comorbidities
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2022

Expires: July 06, 2023

View Activity

Activities

CLL Treatment Tool
Expert Guidance for the Treatment of CLL
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: September 22, 2022

Expires: September 21, 2023

View Activity

Activities

1L Treatment Selection
Choosing Frontline Therapy in Chronic Lymphocytic Leukemia
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2022

Expires: March 03, 2023

View Activity
Slideset: 1L Treatment Selection
Choosing Frontline Therapy in Chronic Lymphocytic Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2022

Expires: March 03, 2023

View Activity
AEs With BCL-2i and PI3Ki
Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2022

Expires: March 16, 2023

View Activity
Slideset: AEs With BCL-2i and PI3Ki
Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2022

Expires: March 16, 2023

View Activity
AEs With BTKis
CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2022

Expires: April 04, 2023

View Activity
Slideset: AEs With BTKi
CLL-Related Symptoms and Managing Adverse Events with BTK Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2022

Expires: April 04, 2023

View Activity
Patient CLL Concerns
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2022

Expires: June 09, 2023

View Activity
Slideset: Patient CLL Concerns
Patient Knowledge Gaps, Concerns, and Misperceptions About CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 13, 2022

Expires: June 12, 2023

View Activity
MRD in CLL
Measurable Residual Disease Assessment in Chronic Lymphocytic Leukemia
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2022

Expires: July 21, 2023

View Activity
Slideset: MRD in CLL
Measurable Residual Disease in CLL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2022

Expires: July 21, 2023

View Activity
CLL Treatment Evolution
Evolution in Expert Recommendations for CLL Treatment
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

View Activity
Slideset: CLL Treatment Evolution
Evolution in Expert Recommendations for CLL Treatment
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: August 15, 2022

Expires: August 14, 2023

View Activity

Activities

1L Therapy
Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: April 19, 2022

Expires: April 18, 2023

View Activity
AEs With BCL-2i/PI3Ki
Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2022

Expires: May 18, 2023

View Activity
AEs With BTKis
Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2022

Expires: May 30, 2023

View Activity
Patient CLL Concerns
Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2022

Expires: August 16, 2023

View Activity
MRD in CLL
Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: August 30, 2022

Expires: August 29, 2023

View Activity
CLL Treatment Evolution
Evolving CLL Treatment Recommendations
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 06, 2022

Expires: October 05, 2023

View Activity

Faculty

cover img faculity

Jennifer Woyach, MD

D Warren Brown Professor of Leukemia Research
Section Head, CLL and Hairy Cell Leukemia
Associate Division Director for Clinical Research
Division of Hematology
Co-Leader Leukemia Research Program
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio

cover img faculity

Farrukh Awan, MD

Professor of Internal Medicine
Director of Lymphoid Malignancies Program
Division of Hematology/Oncology
Harold C. Simmons Compreshensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

cover img faculity

Jennifer R. Brown, MD, PhD

Director, CLL Center & Institute Physician
Dana-Farber Cancer Institute
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Boston, Massachusetts

cover img faculity

Nichole Fisher, RN, BSN

Supervisor, Clinical Research
Willamette Valley Cancer Institute & Research Center
Eugene, Oregon 

cover img faculity

Brian Koffman, MDCM

PCN Content Reviewer
Medical Director, CLL Society Inc.
Partner, St Jude Heritage Medical Group
Diamond Bar, California
Clinical Professor (Retired)
Department of Family Medicine
Keck School of Medicine, USC Family Practice
Los Angeles, California

cover img faculity

Nicole Lamanna, MD

Associate Professor
Leukemia Service
Director of CLL Program
Hematologic Malignancies Section
Department of Medicine
New York-Presbyterian/Columbia University Medical Center
New York, New York

cover img faculity

Shuo Ma, MD, PhD

Professor of Medicine
Division of Hematology-Oncology
Department of Medicine
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

cover img faculity

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

cover img faculity

Lindsey Roeker, MD

cover img faculity

Jeffrey P. Sharman, MD

Medical Director
Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

AstraZeneca

Eli Lilly

Janssen Biotech

Pharmacyclics an AbbVie Company

TG Therapeutics

Partners

CLL Society

ProCE Banner